IRTC Q2 2023 Earnings — iRhythm Technologies, Inc. Revenue & Financial Results | Market Cap Arena

IRTCiRhythm Technologies, Inc.

$4B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$124M+21.6% YoY

Gross Profit

$86M69.5% margin

Operating Income

-$19M-15.2% margin

Net Income

-$18M-14.9% margin

EPS (Diluted)

$-0.61

QoQ Revenue Growth

+11.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$14M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$429M

Total Liabilities

$206M

Stockholders' Equity

$224M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$124M	$102M	+21.6%
Gross Profit	$86M	$70M	+22.7%
Operating Income	-$19M	-$23M	+19.5%
Net Income	-$18M	-$24M	+22.7%

Revenue Segments

Commercial Payors

$67M54%

Centers For Medicare And Medicaid

$31M25%

Healthcare Institutions

$18M15%

Non-Contracted Third-Party Payors

$8M6%